Promoters of Mankind Pharma divest 1.6% stake worth Rs 1,367 crore
On Thursday, shares of Mankind Pharma jumped 5.72 per cent to close at Rs 2,250 apiece on the NSE |
Continue readingThe Number One Finance & Business Blog!
On Thursday, shares of Mankind Pharma jumped 5.72 per cent to close at Rs 2,250 apiece on the NSE |
Continue readingIndian pharmaceutical firm Dr Reddy’s Laboratories beat estimates for third-quarter profit on Tuesday, helped by strong performance in its
Continue readingMumbai-headquartered Cipla saw a 32 per cent surge in year-on-year (Y-o-Y) net profit at Rs 1,055.9 crore for the
Continue readingThe settlement is the latest in a years-long effort to hold McKinsey accountable for its role in the opioid epidemic.
Continue readingLupin Atlantis Holdings, a wholly-owned subsidiary of Lupin, has signed an Asset Purchase Agreement with French pharmaceutical company Sanofi.
Continue readingZydus Worldwide DMCC, a wholly-owned subsidiary of Zydus Lifesciences Ltd and Daewoong Pharmaceutical Co Ltd, has entered into a
Continue readingDr Reddy’s Laboratories (DRL) said on Wednesday that it has entered into an exclusive collaboration with US-based Coya Therapeutics
Continue readingGlobal pharma major Lupin on Thursday announced the launch of Vilfuro-G, the world’s first fixed-dose triple combination drug (FDC) for
Continue readingNew Jersey-based and wholly-owned subsidiary of Aurobindo Pharma USA, Acrotech Biopharma, and Evive Biotech, a biopharmaceutical company and subsidiary of
Continue readingBy Anna Edney Kilitch Healthcare India Ltd. recalled 27 types of eyedrops sold in US stores nationwide because
Continue reading